In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp
Hugo Prazeres(Instituto Português de Oncologia de Coimbra Francisco Gentil), Paula Soares(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto)
Cited by 13
Related Papers
The mTOR Signalling Pathway in Human Cancer
|International Journal of Molecular Sciences|2012|831
AZD1480 Blocks Growth and Tumorigenesis of RET- Activated Thyroid Cancer Cell Lines
|PLoS ONE|2012|24
TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
|Scientific Reports|2016|19
Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma
|International Journal of Molecular Sciences|2024|3